Pharma Industry News Weekly Recap: March 17, 2023
// Biotech and Pharma Therapeutics Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US March [...]
// Biotech and Pharma Therapeutics Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US March [...]
// Biotech and Pharma Therapeutics With PCSK9 pill, Merck aims to succeed where others failed March 7, 2023 / [...]
// Biotech and Pharma Therapeutics After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year [...]
// Biotech and Pharma Therapeutics Eli Lilly's diabetes drug Mounjaro back in stock amid heightened obesity interest February [...]
// Biotech and Pharma Therapeutics Faced with safety issues over inflammation drug, AstraZeneca spinout Aristea closes shop February [...]
// Biotech and Pharma Therapeutics AstraZeneca deals another blow to IL-12, dumping therapy to follow BMS, Merck KGaA out [...]
// Biotech and Pharma Therapeutics Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s [...]
// Biotech and Pharma Therapeutics J&J puts focus on cancer drugs in push to reach 2025 sales target [...]
// Biotech and Pharma Therapeutics AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid [...]
// Biotech and Pharma Therapeutics Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV [...]